Literature DB >> 17377172

Statins and the effect of BCG on bladder cancer.

Ashish M Kamat, Xifeng Wu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377172     DOI: 10.1056/NEJMc070117

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.

Authors:  Ashish M Kamat; Thomas W Flaig; H Barton Grossman; Badrinath Konety; Donald Lamm; Michael A O'Donnell; Edward Uchio; Jason A Efstathiou; John A Taylor
Journal:  Nat Rev Urol       Date:  2015-03-24       Impact factor: 14.432

2.  Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.

Authors:  Nirmish Singla; Ahmed Q Haddad; Niccolo M Passoni; Matthew Meissner; Yair Lotan
Journal:  World J Urol       Date:  2016-05-18       Impact factor: 4.226

3.  Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Ju Hyun Lim; In Gab Jeong; Jong Yeon Park; Dalsan You; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2015-06-30

4.  Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

Authors:  Kyle B Zuniga; Rebecca E Graff; David B Feiger; Maxwell V Meng; Sima P Porten; Stacey A Kenfield
Journal:  Bladder Cancer       Date:  2020-03-28

5.  Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette-Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zhiyong Cai; Jiao Hu; Belaydi Othmane; Huihuang Li; Dongxu Qiu; Zhenglin Yi; Jinbo Chen; Xiongbing Zu
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.